Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the company and its research collaborators will present 25 abstracts—including five rapid oral ...

Dr. Roach weighs in on whether a patient should proceed with a prostate biopsy after conflicting test results.

A doctor advises a 68-year-old patient with a high 4Kscore result to proceed with a prostate biopsy despite a low-risk MRI.

A physician advises a 68-year-old patient with a high 4Kscore result to consider a prostate biopsy despite being on warfarin, ...

A conflicting MRI result and the complications of blood thinner use have left one 68-year-old man and his physician at a crossroads.

I am 68 years old and have an enlarged prostate and benign prostatic hyperplasia (BPH). I’ve been taking tamsulosin for about ...

However, I think there are a number of other tests that could be done, such as a Prostate Health Index (phi) test or perhaps others. Would I benefit from taking a different test, or should we stick ...

Since there were no particular issues with the pre-admission tests, it was decided that I would undergo a prostate biopsy ...

Prostate cancer patients are benefitting from a machine that delivers radiotherapy treatment faster. The radiotherapy team at ...

(NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) today announced that five abstracts presented at the 15th Interventional MRI (“iMRI”) Symposium in Boston, Massachusetts, reinforce the growing ...

Prostate cancer can be a serious disease, but most men diagnosed with prostate cancer do not die from it. In fact, more than 3.5 million men in the United States who have been diagnosed with prostate ...

A new study by the Medical University of Vienna found that a specialized form of imaging could identify 91% of prostate ...